Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients.
作者： Daniel C. Brennan , Kathy A. Garlock , Gary G. Singer , Mark A. Schnitzler , Bruce J. Lippmann
DOI: 10.1097/00007890-199712270-00036
关键词: Chemoprophylaxis 、 Kidney disease 、 Surgery 、 Aciclovir 、 Ganciclovir 、 Transplantation 、 Opportunistic infection 、 Health administration 、 Medicine 、 General surgery 、 Congenital cytomegalovirus infection
摘要: 5 Barnes-Jewish Hospital. 6 Health Administration Program, Washington University School of Medicine. 7 Department Pediatrics, 8 General Surgery, Transplantation Section, t This work is dedicated to the memory James A. Crook, our patient and teacher.
elsevier.com
lww.com 
sci-hub.st 参考文章(9)
P Schäfer, W Tenschert, K Gutensohn, R Laufs, Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay. Journal of Clinical Microbiology. ,vol. 35, pp. 741- 744 ,(1997) , 10.1128/JCM.35.3.741-744.1997
Robin Patel, David R. Snydman, Robert H. Rubin, Monto Ho, Mark Pescovitz, Maureen Martin, Carlos V. Paya, Cytomegalovirus prophylaxis in solid organ transplant recipients. Transplantation. ,vol. 61, pp. 1279- 1289 ,(1996) , 10.1097/00007890-199605150-00001
Thomas C. Bailey, Neil A. Ettinger, Gregory A. Storch, Elbert P. Trulock, Douglas W. Hanto, W.Claiborne Dunagan, Martin D. Jendrisak, Christopher S. McCullough, Joseph L. Kenzora, William G. Powderly, Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants The American Journal of Medicine. ,vol. 95, pp. 273- 278 ,(1993) , 10.1016/0002-9343(93)90279-X
Henry H. Balfour, Beverly A. Chace, Jack T. Stapleton, Richard L. Simmons, David S. Fryd, A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts The New England Journal of Medicine. ,vol. 320, pp. 1381- 1387 ,(1989) , 10.1056/NEJM198905253202105
EMANUEL FARRUGIA, THOMAS R. SCHWAB, Management and Prevention of Cytomegalovirus Infection After Renal Transplantation Mayo Clinic Proceedings. ,vol. 67, pp. 879- 890 ,(1992) , 10.1016/S0025-6196(12)60828-3
K.i.m. Solez, Roy A. Axelsen, Hallgrimur Benediktsson, James F. Burdick, Arthur H. Cohen, Robert B. Colvin, Byron P. Croker, Dominique Droz, Michael S. Dunnill, Philip F. Halloran, Pekka Häyry, J. Charles Jennette, Paul A. Keown, Niels Marcussen, Michael J. Mihatsch, Kunio Morozumi, Bryan D. Myers, Cynthia C. Nast, Steen Olsen, Lorraine C. Racusen, Eleanor L. Ramos, Seymour Rosen, David H. Sachs, Daniel R. Salomon, Fred Sanfilippo, Regina Verani, Eeva von Willebrand, Yutaka Yamaguchi, International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology Kidney International. ,vol. 44, pp. 411- 422 ,(1993) , 10.1038/KI.1993.259
J Kletzmayr, J Kovarik, R Klauser, T Popow-Kraupp, H Kotzmann, Impact of high-dose oral acyclovir prophylaxis on cytomegalovirus (CMV) disease in CMV high-risk renal transplant recipients. Journal of The American Society of Nephrology. ,vol. 7, pp. 325- 330 ,(1996) , 10.1681/ASN.V72325
Gregory A. Storch, Monique Gaudreault-Keener, Steven B. Miller, Todd K. Howard, Jeffrey A. Lowell, Richard S. Buller, Daniel C. Brennan, Surendra Shenoy, Kathy A. Garlock, Bruce A. Lippmann, Control of cytomegalovirus-associated morbidity in renal transplant patients using intensive monitoring and either preemptive or deferred therapy. Journal of The American Society of Nephrology. ,vol. 8, pp. 118- 125 ,(1997) , 10.1681/ASN.V81118
C. S. Crumpacker, Drug therapy : Ganciclovir The New England Journal of Medicine. ,vol. 335, pp. 721- 729 ,(1996)